Business Context and Reporting Period
This Form 8-K Current Report was filed by NeoGenomics, Inc. on August 7, 2026, covering events reported as of that date. The filing primarily addresses executive leadership changes within the company.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and personnel matters rather than financial performance data.
Material Changes
The material change disclosed is the departure of a senior executive:
- Alicia Olivo, Executive Vice President, General Counsel & Business Development, will cease serving as General Counsel effective September 21, 2026.
- Ms. Olivo will remain an employee until October 2, 2026 for transitional purposes.
- She is eligible for separation payments and benefits consistent with Section 5(b) of her employment agreement.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure of executive departure. No unusual items or contingencies were reported in this document.
Key Facts for Investor Verification
- Verify the specific terms of the separation agreement referenced in the 2025 Form 10-K to understand potential financial impact.
- Monitor subsequent filings for the appointment of a new General Counsel or interim replacement.
- Confirm the exact end date of Ms. Olivo's employment (October 2, 2026) for transition planning.